Washington, District of Columbia 20111

  • Hemangioma of Infancy

Purpose:

Hemangiomas are relatively common lesions in infants. Most go away spontaneously after one year of life and do not need treatment. Others require treatment because they cause significant symptoms such as pain, or difficulty with breathing, eating or ambulating. Steroids have classically been used to treat hemangiomas and help to shrink them in 1/3 - 2/3 of patients. Unfortunately, steroids have many side effects in babies so physicians have sought other ways to treat them. Recently, the use of propranolol, a heart medication, was serendipitously found to reduce the size of hemangiomas. It appears to have many fewer side effects than steroids but it is not yet known if it works as well as steroids. This study seeks to compare the effect and the side effects of propranolol versus steroids for treating hemangiomas that cause symptoms in infants.


Study summary:

Infants with symptomatic hemangiomas will be enrolled. Magnetic resonance imaging will be completed before starting medication if the extent of the hemangioma is not evident on clinical examination alone. Infants will be randomized to receive either propranolol or steroids for 4-6 months. Hemangioma response will be measured and compared monthly as will tolerability of the medications. Additionally, urine specimens will be collected at each visit to determine if markers are present that can predict response to therapy. Additionally, any hemangiomas that are excised will be examined for genetic markers to aid in predicting response to therapy.


Criteria:

Inclusion Criteria: - infants with symptomatic hemangiomas Exclusion Criteria: - asthma - diabetes - hypertension - hypotension - hypoglycemia - liver failure - previous treatment for hemangiomas


NCT ID:

NCT00967226


Primary Contact:

Principal Investigator
Nancy M Bauman, MD
Children's Research Institute, Children's National Medical Center

Jennifer Gode, RN
Phone: 202 476 4270
Email: jgode@cnmc.org


Backup Contact:

Nancy Bauman, MD
Phone: 202 476 4270


Location Contact:

Washington, District of Columbia 20111
United States

Jennifer Gode, RN
Phone: 202-476-4270
Email: jgode@cnmc.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 27, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.